Last month, the final draft of the German 'Gender Incongruence and Gender Dysphoria in Childhood and Adolescence” guideline drew attention for the highly medicalization-focused nature of its recommendations.

In response, 15 professors from the German Society for Child and…

Following the Cass Report, Wales and Scotland joined England in stopping new prescriptions of puberty blockers as a treatment for gender dysphoria in youth <18.

Scotland's policy goes even further than England's.
While in England, cross-sex hormones can still be prescribed…

The BBC investigated the source of the myth that the Cass Report 'ignored 98% of the evidence'.

Dr. Cass is clear: 'Adults who deliberately spread misinformation about this topic are putting young people at risk, and in my view, that is unforgivable.'
bbc.co.uk/sounds/play/w3……

Amsterdam UMC—the Dutch clinic that pioneered the practice of youth gender transitions—has responded to the Cass Report. It praised many aspects of the Report but disagreed with the conclusion that the evidence for puberty blockers is insufficient.

amsterdamumc.org/nl/vandaag/een…

'As a…

The Telegraph profiled Prof. Sallie Baxendale and how her concerns about the lack of research into the effects of puberty blockers on brain development were silenced. Prof. Baxendale presented her research at SEGM's conference.

telegraph.co.uk/news/2024/04/1…

msn.com/en-gb/health/o…

“One emerging criticism of the Cass review is that it set the methodological bar too high for research to be included in its analysis and discarded too many studies on the basis of quality. In fact, the reality is different: studies in gender medicine fall woefully short.”…

From the BMJ editor-in-chief.